Single-cell and Spatial Transcriptomics Reveals Ferroptosis as The Most Enriched Programmed Cell Death Process in

Lingui Gu1, Hualin Chen1, Ruxu Geng2

  • 1Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.

Insights

Intracerebral hemorrhage (ICH) triggers ferroptosis, a programmed cell death, primarily in oligodendrocytes. Targeting microglial lipocalin-2 (LCN2) offers a neuroprotective strategy against ICH-induced damage.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pathology

Background:

  • Intracerebral hemorrhage (ICH) is a severe stroke with limited treatments.
  • Programmed cell death (PCD) encompasses multiple pathways, including ferroptosis, crucial for tissue homeostasis.
  • Understanding PCD modalities post-ICH is vital for developing effective therapies.

Purpose of the Study:

  • To investigate programmed cell death (PCD) gene expression in the rat brain after intracerebral hemorrhage (ICH).
  • To identify the predominant PCD mechanism and affected cell types following hemorrhagic stroke.
  • To elucidate molecular pathways driving cell death and neurological deficits post-ICH.

Main Methods:

  • Single-cell RNA sequencing and spatial transcriptomics were employed to analyze gene expression.
  • Rats underwent induced intracerebral hemorrhage to model stroke.
  • Analysis focused on programmed cell death-related genes and cellular interactions.

Main Results:

  • Ferroptosis was identified as the primary PCD pathway after ICH, affecting mature oligodendrocytes.
  • Ferroptosis onset was observed as early as 1 hour post-ICH, peaking at 24 hours.
  • A lipocalin-2 (LCN2)-microglia to oligodendrocyte signaling pathway involving CSF1/CSF1R was implicated in ferroptosis induction.

Conclusions:

  • Ferroptosis is the principal PCD mechanism in intracerebral hemorrhage, initiating rapidly.
  • Targeting microglial LCN2 expression presents a potential therapeutic avenue to mitigate oligodendrocyte damage and neurological deficits.
  • This study offers a novel neuroprotective strategy for intracerebral hemorrhage treatment.